Skip Navigation


Annals of Oncology Advance Access originally published online on May 3, 2005
Annals of Oncology 2005 16(9):1557-1558; doi:10.1093/annonc/mdi261
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/9/1557    most recent
mdi261v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alliot, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alliot, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Relevance of EGFR expression in colorectal cancer

The first 10% of the full text of this article appears below.

In a recent issue of Annals of Oncology, Spano and colleagues reported their study of epidermal growth factor receptor (EGFR) expression by immunohistochemistry in 148 patients with colorectal cancer [1Go]. The aim of this study was to analyse the relationship between EGFR reactivity and . . . [Full Text of this Article]

C. Alliot*

Hematology/Oncology Division, General Hospital of Annemasse, France

(* Email: alliotcfr@yahoo.fr)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?